bluebird bio (BLUE) News Today $0.56 -0.03 (-5.22%) (As of 08/30/2024 08:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period August 30, 2024 | marketbeat.combluebird bio, Inc. (NASDAQ:BLUE) Sees Significant Increase in Short Interestbluebird bio, Inc. (NASDAQ:BLUE - Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling 41,140,000 shares, a growth of 32.2% from the July 31st total of 31,130,000 shares. Based on an average trading volume of 6,720,000 shares, the short-interest ratio is currently 6.1 days.August 28, 2024 | finance.yahoo.combluebird bio Announces September Investor EventsAugust 24, 2024 | businesswire.combluebird bio Announces Receipt of Expected Notices from NasdaqAugust 19, 2024 | marketbeat.combluebird bio, Inc. to Post Q2 2024 Earnings of ($0.63) Per Share, William Blair Forecasts (NASDAQ:BLUE)bluebird bio, Inc. (NASDAQ:BLUE - Free Report) - Stock analysts at William Blair decreased their Q2 2024 earnings estimates for bluebird bio in a research report issued to clients and investors on Wednesday, August 14th. William Blair analyst S. Corwin now anticipates that the biotechnology compaAugust 16, 2024 | finance.yahoo.comZealand, Arrowhead advance obesity drugs; Bluebird narrows guidanceAugust 16, 2024 | msn.comJP Morgan Downgrades bluebird bio (BLUE)August 16, 2024 | markets.businessinsider.comBluebird Bio: A Hold Rating Amid Operational Challenges and Financial UncertaintyAugust 15, 2024 | marketbeat.combluebird bio (NASDAQ:BLUE) PT Lowered to $3.00 at Bank of AmericaBank of America reduced their price objective on shares of bluebird bio from $4.00 to $3.00 and set a "buy" rating on the stock in a research report on Thursday.August 15, 2024 | markets.businessinsider.comMaintaining Buy Rating on Bluebird Bio Amidst Conservative Revenue Projections for LyfgeniaAugust 15, 2024 | marketbeat.combluebird bio (NASDAQ:BLUE) Given "Sector Perform" Rating at Royal Bank of CanadaRoyal Bank of Canada reissued a "sector perform" rating and issued a $4.00 price target on shares of bluebird bio in a research note on Thursday.August 15, 2024 | finance.yahoo.comQ2 2024 bluebird bio Inc Earnings CallAugust 15, 2024 | bizjournals.comBluebird lowers expectations for patients starting gene therapiesAugust 15, 2024 | marketbeat.combluebird bio, Inc. (NASDAQ:BLUE) Given Average Recommendation of "Hold" by AnalystsShares of bluebird bio, Inc. (NASDAQ:BLUE - Get Free Report) have been given a consensus rating of "Hold" by the eleven research firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, seven have issued a hold recommendationAugust 14, 2024 | seekingalpha.combluebird bio, Inc. (BLUE) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.combluebird bio slips as 2024 guidance underwhelmsAugust 14, 2024 | seekingalpha.comCrispr's Casgevy Launch: Promising Start, Uncertain FutureAugust 14, 2024 | finance.yahoo.combluebird bio Reports Second Quarter 2024 Results and Highlights Operational Progress and 2024 GuidanceAugust 14, 2024 | marketbeat.combluebird bio, Inc. (NASDAQ:BLUE) Shares Purchased by Vanguard Group Inc.Vanguard Group Inc. raised its stake in shares of bluebird bio, Inc. (NASDAQ:BLUE - Free Report) by 19.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,498,460 shares of the biotechnology company's stock after buying an additional 1August 13, 2024 | marketbeat.combluebird bio (NASDAQ:BLUE) Stock Price Crosses Below Two Hundred Day Moving Average of $1.10bluebird bio (NASDAQ:BLUE) Stock Passes Below 200 Day Moving Average of $1.10August 13, 2024 | finance.yahoo.combluebird bio Announces Second Quarter 2024 Results Call DateJuly 29, 2024 | finance.yahoo.comWith 57% ownership of the shares, bluebird bio, Inc. (NASDAQ:BLUE) is heavily dominated by institutional ownersJuly 27, 2024 | msn.comOpinion | Rationing for Sickle-Cell TherapiesJuly 27, 2024 | marketbeat.comBNP Paribas Financial Markets Has $131,000 Stake in bluebird bio, Inc. (NASDAQ:BLUE)BNP Paribas Financial Markets trimmed its stake in bluebird bio, Inc. (NASDAQ:BLUE - Free Report) by 80.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 102,100 shares of the biotechnology company's stock after sellJuly 23, 2024 | finance.yahoo.comHHS gives thumbs down to bluebird’s fertility support programmeJuly 20, 2024 | ca.finance.yahoo.comBLUE Nov 2024 2.500 callJuly 12, 2024 | globenewswire.comBLUE ALERT: Bragar Eagel & Squire, P.C. is Investigating Bluebird bio Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJuly 9, 2024 | marketbeat.combluebird bio (NASDAQ:BLUE) Shares Pass Above 50-Day Moving Average of $0.96bluebird bio (NASDAQ:BLUE) Stock Passes Above Fifty Day Moving Average of $0.96July 3, 2024 | businesswire.combluebird bio Reports Inducement Grant to CFO James Sterling Under Nasdaq Listing Rule 5635(c)(4)June 27, 2024 | globenewswire.comBLUE ALERT: Bragar Eagel & Squire, P.C. is Investigating Bluebird bio Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJune 17, 2024 | marketbeat.comShort Interest in bluebird bio, Inc. (NASDAQ:BLUE) Decreases By 7.8%bluebird bio, Inc. (NASDAQ:BLUE - Get Free Report) saw a significant decrease in short interest in the month of May. As of May 31st, there was short interest totalling 29,120,000 shares, a decrease of 7.8% from the May 15th total of 31,600,000 shares. Based on an average trading volume of 6,540,000 shares, the days-to-cover ratio is presently 4.5 days.June 17, 2024 | marketbeat.comHBK Investments L P Acquires Shares of 1,500,000 bluebird bio, Inc. (NASDAQ:BLUE)HBK Investments L P acquired a new stake in bluebird bio, Inc. (NASDAQ:BLUE - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,500,000 shares of the biotechnology company's stock, valued at approximately $2,070June 17, 2024 | investorplace.com7 Breakthrough Biotech Stocks for a Shot of Portfolio AdrenalineJune 12, 2024 | marketbeat.com1,000,000 Shares in bluebird bio, Inc. (NASDAQ:BLUE) Acquired by Masters Capital Management LLCMasters Capital Management LLC acquired a new position in bluebird bio, Inc. (NASDAQ:BLUE - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,000,000 shares of the biotechnology company's stock, valuedJune 10, 2024 | marketbeat.comGhisallo Capital Management LLC Acquires Shares of 3,150,000 bluebird bio, Inc. (NASDAQ:BLUE)Ghisallo Capital Management LLC acquired a new stake in bluebird bio, Inc. (NASDAQ:BLUE - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 3,150,000 shares of the biotechnology company's stock, valued at appJune 9, 2024 | marketbeat.comVestal Point Capital LP Invests $2.97 Million in bluebird bio, Inc. (NASDAQ:BLUE)Vestal Point Capital LP purchased a new stake in shares of bluebird bio, Inc. (NASDAQ:BLUE - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,150,000 shares of the biotechnology company's stock, valued atJune 2, 2024 | prnewswire.com2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a PartnerMay 29, 2024 | reuters.comBluebird bio appoints new CFO to oversee financial restatementsMay 29, 2024 | markets.businessinsider.comBluebird Bio Appoints Sterling As CFOMay 29, 2024 | businesswire.combluebird bio Appoints O. James Sterling as Chief Financial OfficerMay 27, 2024 | stockhouse.comDEADLINE TOMORROW: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the FirmMay 25, 2024 | theglobeandmail.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUEMay 25, 2024 | finance.yahoo.comBLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?May 24, 2024 | tmcnet.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE)May 24, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE)May 23, 2024 | prnewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio Lawsuit - BLUEMay 22, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUEMay 22, 2024 | prnewswire.comBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud LawsuitMay 21, 2024 | prnewswire.comInvestors in bluebird bio, Inc. Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - BLUEMay 17, 2024 | businesswire.comBLUE INVESTOR ALERT: Kirby McInerney LLP Notifies bluebird bio, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitMay 16, 2024 | prnewswire.comBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit Get bluebird bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLUE and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s final twist in Appalachia (Ad)Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place… Go here now to watch my new documentary BLUE Media Mentions By Week BLUE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLUE News Sentiment▼0.670.81▲Average Medical News Sentiment BLUE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLUE Articles This Week▼56▲BLUE Articles Average Week Get bluebird bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLUE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AlloVir News Today Sangamo Therapeutics News Today Greenwich LifeSciences News Today Atyr PHARMA News Today LENZ Therapeutics News Today Allakos News Today Cingulate News Today LianBio News Today NeuroBo Pharmaceuticals News Today PHAXIAM Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLUE) was last updated on 9/3/2024 by MarketBeat.com Staff From Our PartnersFirst Disruption to $martphones in 15 Years 🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredFREE Daily Profits Live Open HouseOver the past year, members of Millionaire trader Nate Bear's Daily Profits Live chatroom have had 62 opportun...Monument Traders Alliance | SponsoredAmazon coin set to soar 25X – starting September 23rdChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredKamala? Trump? _______? Think again. This play has delivered an annualized average gain of nearly 50% in just three months time… before every singl...The Freeport Society | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bluebird bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bluebird bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.